Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-881-4
CAS number: 128-37-0
After a single application of 5 mg 14C-labelled BHT in
acetone to guinea pigs (1.66 mg BHT/cm2), 9.1% of the applied
dose was detected in the urine and 5% in the faeces after 7 days. Total
absorption was 8.5% after 8 days using the lipophilic solvent Labrafil
instead of acetone. After 3 wk of daily dermal application of 5 mg BHT
in Labrafil solution (1.66 mg/cm2) and three applications of 5 mg
radioactiely labelled BHT on test days 1, 8, and 15, a total absorption
of up to 9.1% was determined.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Dette websted anvender cookies for at sikre dig den bedste brugeroplevelse.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again